Nova Patents
IL225631A0

Humanized anti-interleukin 3 receptor alpha chain antibodies

Abstract

This record has no abstract on file.

Term

No projected expiry on record.

  1. Priority
  2. Filed
  3. Published
  4. Today

86 members in 16 offices

This recordMember, by publication datePriority claim6 more offices are in the list below

Priority claims5

Priority claims
DocumentOfficeKindDate
37448910United States of AmericaP
61374489United States of America–
2011000155AustraliaW
PCTAU2011000155World Intellectual Property Organization (WIPO)–
2011001056AustraliaW

Members86

Family members, oldest first
DocumentOfficeKind
US2010209341A1United States of AmericaA1
CA2789515A1CanadaA1
WO2010094068A1World Intellectual Property Organization (WIPO)A1
CA2789810A1CanadaA1
WO2011100786A1World Intellectual Property Organization (WIPO)A1
CA2802046A1CanadaA1
WO2011156398A1World Intellectual Property Organization (WIPO)A1
AU2011253598B1AustraliaB1
CA2805176A1CanadaA1
WO2012021934A1World Intellectual Property Organization (WIPO)A1
IL216628A0IsraelA0
AU2012202125A1AustraliaA1
GB201211289D0United KingdomD0
GB2488091AUnited KingdomA
AU2010215069A1AustraliaA1
AU2011217728A1AustraliaA1
CN102821815AChinaA
EP2536430A1European Patent Office (EPO)A1
EP2536468A1European Patent Office (EPO)A1
AU2011265030A1AustraliaA1
KR20130004576ARepublic of KoreaA
MX2012014376AMexicoA
AU2013200910A1AustraliaA1
AU2011217728B2AustraliaB2
CN103002913AChinaA
KR20130032866ARepublic of KoreaA
CN103025761AChinaA
US2013084282A1United States of AmericaA1
EP2575444A1European Patent Office (EPO)A1
CN103068225AChinaA
US2013101677A1United States of AmericaA1
GB2488091BUnited KingdomB
KR20130047736ARepublic of KoreaA
JP2013519689AJapanA
JP2013519690AJapanA
US2013137855A1United States of AmericaA1
EP2606069A1European Patent Office (EPO)A1
IL225631A0This recordIsraelA0
EP2536468A4European Patent Office (EPO)A4
EP2606069A4European Patent Office (EPO)A4
EP2536430A4European Patent Office (EPO)A4
US8535669B2United States of AmericaB2
JP2013537418AJapanA
NZ601760ANew ZealandA
NZ604510ANew ZealandA
US8569461B2United States of AmericaB2
US8609149B2United States of AmericaB2
EP2575444A4European Patent Office (EPO)A4
KR101347688B1Republic of KoreaB1
US2014086912A1United States of AmericaA1
JP2014076062AJapanA
JP5524418B2JapanB2
US2014178364A1United States of AmericaA1
EP2606069B1European Patent Office (EPO)B1
CN103025761BChinaB
DK2606069T3DenmarkT3
EP2778175A1European Patent Office (EPO)A1
ES2506340T3SpainT3
NZ604237ANew ZealandA
US2015017180A1United States of AmericaA1
AU2011265030B2AustraliaB2
NZ610826ANew ZealandA
PL2606069T3PolandT3
AU2012202125B2AustraliaB2
US2015147322A1United States of AmericaA1
AU2013200910B2AustraliaB2
CA2805176CCanadaC
US2015307615A1United States of AmericaA1
CN103002913BChinaB
CN103068225BChinaB
EP2778175B1European Patent Office (EPO)B1
JP5933517B2JapanB2
JP6018507B2JapanB2
EP2536430B1European Patent Office (EPO)B1
EP2575444B1European Patent Office (EPO)B1
ES2618562T3SpainT3
IL225631AIsraelA
US9758585B2United States of AmericaB2
KR101842907B1Republic of KoreaB1
US10047161B2United States of AmericaB2
CA2802046CCanadaC
IL221504AIsraelA
IL221504BIsraelB
BR112012031189A2BrazilA2
CA2789810CCanadaC
BR112012031189B1BrazilB1